0001179110-17-010591.txt : 20170721
0001179110-17-010591.hdr.sgml : 20170721
20170721161940
ACCESSION NUMBER: 0001179110-17-010591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170719
FILED AS OF DATE: 20170721
DATE AS OF CHANGE: 20170721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reumuth Mary
CENTRAL INDEX KEY: 0001710969
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 17976764
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
edgar.xml
FORM 4 -
X0306
4
2017-07-19
0
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001710969
Reumuth Mary
C/O KALA PHARMACEUTICALS, INC.
100 BEAVER STREET, SUITE 201
WALTHAM
MA
02453
0
1
1
0
Chief Financial Officer
Stock Option (right to buy)
15
2017-07-19
4
A
0
28973
0
A
2027-07-18
Common Stock
28973
28973
D
This option was granted, effective on July 19, 2017 and vests over four years, with 2.0833% of the shares underlying the option vesting on August 31, 2017 and an additional 2.0833% of the shares vesting at the end of each successive one-month period thereafter.
/s/ Mary Reumuth
2017-07-21